Cargando…

Does performance-based financing increase value for money in low- and middle- income countries? A systematic review

Governments of low- and middle-income countries (LMICs) are widely implementing performance-based financing (PBF) to improve healthcare services. However, it is unclear whether PBF provides good value for money compared to status quo or other interventions aimed at strengthening the healthcare syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Turcotte-Tremblay, Anne-Marie, Spagnolo, Jessica, De Allegri, Manuela, Ridde, Valéry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967066/
https://www.ncbi.nlm.nih.gov/pubmed/27472942
http://dx.doi.org/10.1186/s13561-016-0103-9
_version_ 1782445474907684864
author Turcotte-Tremblay, Anne-Marie
Spagnolo, Jessica
De Allegri, Manuela
Ridde, Valéry
author_facet Turcotte-Tremblay, Anne-Marie
Spagnolo, Jessica
De Allegri, Manuela
Ridde, Valéry
author_sort Turcotte-Tremblay, Anne-Marie
collection PubMed
description Governments of low- and middle-income countries (LMICs) are widely implementing performance-based financing (PBF) to improve healthcare services. However, it is unclear whether PBF provides good value for money compared to status quo or other interventions aimed at strengthening the healthcare system in LMICs. The objective of this systematic review is to identify and synthesize the existing literature that examines whether PBF represents an efficient manner of investing resources. We considered PBF to be efficient when improved care quality or quantity was achieved with equal or lower costs, or alternatively, when the same quality of care was achieved using less financial resources. A manual search of the reference lists of two recent systematic reviews on economic evaluations of PBF was conducted to identify articles that met our inclusion and exclusion criteria. Subsequently, a search strategy was developed with the help of a librarian. The following databases and search engines were used: PubMed, EconLit, Google Scholar and Google. Experts on economic evaluations were consulted for validation of the selected studies. A total of seven articles from five LMICs were selected for this review. We found the overall strength of the evidence to be weak. None of the articles were full economic evaluations; they did not make clear connections between the costs and effects of PBF. Only one study reported using a randomized controlled trial, but issues with the randomization procedure were reported. Important alternative interventions to strengthen the capacities of the healthcare system have not been considered. Few studies examined the costs and consequences of PBF in the long term. Important costs and consequences were omitted from the evaluations. Few LMICs are represented in the literature, despite wide implementation. Lastly, most articles had at least one author employed by an organization involved in the implementation of PBF, thereby resulting in potential conflicts of interest. Stronger empirical evidence on whether PBF represents good value for money in LMICs is needed.
format Online
Article
Text
id pubmed-4967066
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49670662016-08-11 Does performance-based financing increase value for money in low- and middle- income countries? A systematic review Turcotte-Tremblay, Anne-Marie Spagnolo, Jessica De Allegri, Manuela Ridde, Valéry Health Econ Rev Review Governments of low- and middle-income countries (LMICs) are widely implementing performance-based financing (PBF) to improve healthcare services. However, it is unclear whether PBF provides good value for money compared to status quo or other interventions aimed at strengthening the healthcare system in LMICs. The objective of this systematic review is to identify and synthesize the existing literature that examines whether PBF represents an efficient manner of investing resources. We considered PBF to be efficient when improved care quality or quantity was achieved with equal or lower costs, or alternatively, when the same quality of care was achieved using less financial resources. A manual search of the reference lists of two recent systematic reviews on economic evaluations of PBF was conducted to identify articles that met our inclusion and exclusion criteria. Subsequently, a search strategy was developed with the help of a librarian. The following databases and search engines were used: PubMed, EconLit, Google Scholar and Google. Experts on economic evaluations were consulted for validation of the selected studies. A total of seven articles from five LMICs were selected for this review. We found the overall strength of the evidence to be weak. None of the articles were full economic evaluations; they did not make clear connections between the costs and effects of PBF. Only one study reported using a randomized controlled trial, but issues with the randomization procedure were reported. Important alternative interventions to strengthen the capacities of the healthcare system have not been considered. Few studies examined the costs and consequences of PBF in the long term. Important costs and consequences were omitted from the evaluations. Few LMICs are represented in the literature, despite wide implementation. Lastly, most articles had at least one author employed by an organization involved in the implementation of PBF, thereby resulting in potential conflicts of interest. Stronger empirical evidence on whether PBF represents good value for money in LMICs is needed. Springer Berlin Heidelberg 2016-07-29 /pmc/articles/PMC4967066/ /pubmed/27472942 http://dx.doi.org/10.1186/s13561-016-0103-9 Text en © Turcotte-Tremblay et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Turcotte-Tremblay, Anne-Marie
Spagnolo, Jessica
De Allegri, Manuela
Ridde, Valéry
Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title_full Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title_fullStr Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title_full_unstemmed Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title_short Does performance-based financing increase value for money in low- and middle- income countries? A systematic review
title_sort does performance-based financing increase value for money in low- and middle- income countries? a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967066/
https://www.ncbi.nlm.nih.gov/pubmed/27472942
http://dx.doi.org/10.1186/s13561-016-0103-9
work_keys_str_mv AT turcottetremblayannemarie doesperformancebasedfinancingincreasevalueformoneyinlowandmiddleincomecountriesasystematicreview
AT spagnolojessica doesperformancebasedfinancingincreasevalueformoneyinlowandmiddleincomecountriesasystematicreview
AT deallegrimanuela doesperformancebasedfinancingincreasevalueformoneyinlowandmiddleincomecountriesasystematicreview
AT riddevalery doesperformancebasedfinancingincreasevalueformoneyinlowandmiddleincomecountriesasystematicreview